ArticleBiomaterials research2026

Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy.

Shu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.